Authors: GREEN L RAYTER Z CALDER C FARDON JR

Citation: L. Green et al., PROGNOSTIC MARKERS IN NEOADJUVANT CHEMOTHERAPY, European journal of cancer, 34, 1998, pp. 491-491

Authors: BROWN CM CALDER C LINTON C SMALL C KENNY BA SPEDDING M PATMORE L

Citation: Cm. Brown et al., NEUROPROTECTIVE PROPERTIES OF LIFARIZINE COMPARED WITH THOSE OF OTHERAGENTS IN A MOUSE MODEL OF FOCAL CEREBRAL-ISCHEMIA, British Journal of Pharmacology, 115(8), 1995, pp. 1425-1432

Authors: ALPS BJ CALDER C WILSON AD MCBEAN DE ARMSTRONG JM

Citation: Bj. Alps et al., REDUCTION BY LIFARIZINE OF THE NEURONAL DAMAGE-INDUCED BY CEREBRAL-ISCHEMIA IN RODENTS, British Journal of Pharmacology, 115(8), 1995, pp. 1439-1446

Authors: OCONNELL JE CALDER C RAAFAT F PROOPS D

Citation: Je. Oconnell et al., EWINGS-SARCOMA OF THE RETROPHARYNX, Journal of Laryngology and Otology, 108(4), 1994, pp. 363-366

Authors: PARK H CALDER C

Citation: H. Park et C. Calder, LASER-GENERATED RAYLEIGH-WAVES IN GRAPHITE-EPOXY COMPOSITES, Experimental mechanics, 34(2), 1994, pp. 148-154

Authors: BROWN CM CALDER C ALPS BJ SPEDDING M

Citation: Cm. Brown et al., THE EFFECT OF LIFARIZINE (RS-87476), A NOVEL SODIUM AND CALCIUM-CHANNEL MODULATOR, ON ISCHEMIC DOPAMINE DEPLETION IN THE CORPUS STRIATUM OFTHE GERBIL, British Journal of Pharmacology, 109(1), 1993, pp. 175-177